Pretraga

Rezultati

Clinical significance of genetic aberrations in secondary acute myeloid leukemia [2012]

Milosevic, Jelena D.; Puda, Ana; Malcovati, Luca; Berg, Tiina; Hofbauer, Michael; Stukalov, Alexey; Klampfl, Thorsten; Harutyunyan, Ashot S.; Gisslinger, Heinz; Gisslinger, Bettina;

Burjanivova, Tatiana; Rumi, Elisa; Pietra, Daniela; Elena, Chiara; Vannucchi, Alessandro M.; Doubek, Michael; Dvorakova, Dana; Robesova, Blanka; Wieser, Rotraud; Koller, Elisabeth; Suvajdžić-Vuković, Nada ; Tomin, Dragica ; Tošić, Nataša ; Colinge, Jacques; Racil, Zdenek; Steurer, Michael; Pavlović, Sonja ; Cazzola, Mario; Kralovics, Robert;

Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin [2019]

Lauseker, Michael; ...; Bogdanović, Andrija D. ; ...; (broj koautora 22)

The implication and consequence of CD34+cell/subset quantity/ratio on the clinical outcome of hematologic malignancies treated by autologous stem cell transplants [2021]

Todorović, Milena R. ; Pavlović, Mirjana A.; Bila, Jelena S. ; Balint, Bela J.

Frequency of the hemochromatosis gene mutations in patients with hereditary hemochromatosis and in control subjects from serbia and montenegro [2007]

Šarić, M.; Zamurović, Lj.; Kečkarević-Marković, M. ; Kečkarević, Dušan ; Kecmanović, Miljana ; Savić-Pavićević, Dušanka ; Jović, J.; Romac, Stanka

The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera [2024]

Krecak, Ivan; Leković, Danijela R. ; Arsenović, Isidora; Holik, Hrvoje; Zekanovic, Ivan; Moric-Peric, Martina; Lucijanic, Marko

Nitric oxide and hypoxia stimulate and regulate erythropoietin receptor in endothelial cells [2011]

Beleslin-Čokić, Bojana ; Čokić, Vladan ; Noguchi, CT

The effect of inactivated VHL gene on proliferative pathways in renal cell carcinoma [2015]

Beleslin-Čokić, Bojana ; Noguchi, Constance T.; Čokić, Vladan ; Damjanović, Svetozar

Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial [2022]

Terpos, Evangelos; ...; Bila, Jelena S. ; ...; (broj koautora 23)

Outcomes after 18 months of eliglustat therapy in treatment-naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial [2017]

Mistry, Pramod K.; Lukina, Elena; Ben, Turkia Hadhami; Shankar, Suma P.; Baris, Hagit; Ghosn, Marwan; Mehta, Atul; Packman, Seymour; Pastores, Gregory; Petakov, Milan ;

Assouline, Sarit; Balwani, Manisha; Danda, Sumita; Hadjiev, Evgueniy; Ortega, Andres; Gaemers, Sebastiaan J. M.; Tayag, Regina; Peterschmitt, Judith M.;

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL [2023]

Visentin, Andrea; Antić, Darko A. ; ...; Milošević, Ivana D. ; ...; (broj koautora 121)